Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.

van der Meer PB, Habets EJJ, Wiggenraad RG, Verbeek-de Kanter A, Lycklama À Nijeholt GJ, Zwinkels H, Klein M, Dirven L, Taphoorn MJB.

J Neurooncol. 2018 Apr 16. doi: 10.1007/s11060-018-2868-7. [Epub ahead of print]

PMID:
29663172
2.

Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fraction.

Goh VJ, Tromp J, Teng TK, Tay WT, Van Der Meer P, Ling LH, Siswanto BB, Hung CL, Shimizu W, Zhang S, Narasimhan C, Yu CM, Park SW, Ngarmukos T, Liew HB, Reyes E, Yap J, MacDonald M, Richards MA, Anand I, Lam CSP; ASIAN-HF investigators.

ESC Heart Fail. 2018 Mar 31. doi: 10.1002/ehf2.12279. [Epub ahead of print]

PMID:
29604185
3.

Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.

Sliwa K, Petrie MC, Hilfiker-Kleiner D, Mebazaa A, Jackson A, Johnson MR, van der Meer P, Mbakwem A, Bauersachs J.

Eur J Heart Fail. 2018 Mar 26. doi: 10.1002/ejhf.1178. [Epub ahead of print]

PMID:
29578284
4.

A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology.

Salunkhe V, De Cuyper IM, Papadopoulos P, van der Meer PF, Daal BB, Villa-Fajardo M, de Korte D, van den Berg TK, Gutiérrez L.

Platelets. 2018 Mar 19:1-12. doi: 10.1080/09537104.2018.1447658. [Epub ahead of print]

PMID:
29553857
5.

Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General Population.

Eisenga MF, Kieneker LM, Touw DJ, Nolte IM, van der Meer P, Huls G, Gaillard CAJM, Bakker SJL.

Mayo Clin Proc. 2018 Mar;93(3):337-343. doi: 10.1016/j.mayocp.2018.01.005.

PMID:
29502563
6.

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.

Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, Rodenburg RJ, van Veldhuisen DJ, de Boer RA, van der Meer P.

Eur J Heart Fail. 2018 Feb 27. doi: 10.1002/ejhf.1154. [Epub ahead of print]

PMID:
29484788
7.

The Failing Heart Stimulates Tumor Growth by Circulating Factors.

Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, van Veldhuisen DJ, Westenbrink BD, van der Meer P, Silljé HHW, de Boer RA.

Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.030816. doi: 10.1161/CIRCULATIONAHA.117.030816. [Epub ahead of print]

PMID:
29459363
8.

Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.

Ovchinnikova E, Hoes M, Ustyantsev K, Bomer N, de Jong TV, van der Mei H, Berezikov E, van der Meer P.

Stem Cell Reports. 2018 Mar 13;10(3):794-807. doi: 10.1016/j.stemcr.2018.01.016. Epub 2018 Feb 15.

9.

Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.

van Hout FMA, van der Meer PF, Wiersum-Osselton JC, Middelburg RA, Schipperus MR, van der Bom JG, Kerkhoffs JL.

Transfusion. 2018 Apr;58(4):1021-1027. doi: 10.1111/trf.14509. Epub 2018 Feb 6.

PMID:
29405304
10.

Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.

Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, Swinkels DW, van Pelt J, Mulder AB, Bulstra SK, Vellenga E, Mariani MA, de Boer RA, van Veldhuisen DJ, van der Meer P.

Circ Heart Fail. 2018 Feb;11(2):e004519. doi: 10.1161/CIRCHEARTFAILURE.117.004519.

PMID:
29382661
11.

N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure.

Tromp J, Richards AM, Tay WT, Teng TK, Yeo PSD, Sim D, Jaufeerally F, Leong G, Ong HY, Ling LH, van Veldhuisen DJ, Jaarsma T, Voors AA, van der Meer P, de Boer RA, Lam CSP.

ESC Heart Fail. 2018 Apr;5(2):279-287. doi: 10.1002/ehf2.12252. Epub 2018 Jan 30.

12.

Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations.

van der Meer P, Grote Beverborg N, Pfeffer MA, Olson K, Anand IS, Westenbrink BD, McMurray JJV, Swedberg K, Young JB, Solomon SD, van Veldhuisen DJ.

Circ Heart Fail. 2018 Feb;11(2):e004431. doi: 10.1161/CIRCHEARTFAILURE.117.004431.

PMID:
29367268
13.

Predicting heart failure: one size does not fit all.

Tromp J, van der Meer P.

Eur J Heart Fail. 2018 Apr;20(4):674-676. doi: 10.1002/ejhf.1120. Epub 2018 Jan 15. No abstract available.

PMID:
29333673
14.

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.

Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P.

Eur J Heart Fail. 2018 Jan 12. doi: 10.1002/ejhf.1079. [Epub ahead of print]

PMID:
29327797
15.

Why the European Union needs a national GMO opt-in mechanism.

Eriksson D, de Andrade E, Bohanec B, Chatzopolou S, Defez R, Eriksson NL, van der Meer P, van der Meulen B, Ritala A, Sági L, Schiemann J, Twardowski T, Vaněk T.

Nat Biotechnol. 2018 Jan 10;36(1):18-19. doi: 10.1038/nbt.4051. No abstract available.

PMID:
29319683
16.

Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.

McDonald K, Troughton R, Dahlström U, Dargie H, Krum H, van der Meer P, McDonagh T, Atherton JJ, Kupfer K, San George RC, Richards M, Doughty R.

Eur J Heart Fail. 2018 Mar;20(3):474-480. doi: 10.1002/ejhf.1053. Epub 2018 Jan 4.

PMID:
29314505
17.

Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.

Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH.

Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.

PMID:
29306478
18.

Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide.

Klaassen SHC, Tromp J, Nienhuis HLA, van der Meer P, van den Berg MP, Blokzijl H, van Veldhuisen DJ, Hazenberg BPC.

Am J Cardiol. 2018 Jan 1;121(1):107-112. doi: 10.1016/j.amjcard.2017.09.029. Epub 2017 Oct 14.

19.

Single-Cell Functional Analysis of Stem-Cell Derived Cardiomyocytes on Micropatterned Flexible Substrates.

Kijlstra JD, Hu D, van der Meer P, Domian IJ.

Curr Protoc Stem Cell Biol. 2017 Nov 15;43:1F.20.1-1F.20.9. doi: 10.1002/cpsc.40.

PMID:
29140569
20.

Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma.

Klein Hesselink MS, Bocca G, Hummel YM, Brouwers AH, Burgerhof JGM, van Dam EWCM, Gietema JA, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Meer P, Links TP, Tissing WJE.

Thyroid. 2017 Dec;27(12):1481-1489. doi: 10.1089/thy.2017.0383.

PMID:
29132262
21.

Anemia in Heart Failure: Still Relevant?

Grote Beverborg N, van Veldhuisen DJ, van der Meer P.

JACC Heart Fail. 2018 Mar;6(3):201-208. doi: 10.1016/j.jchf.2017.08.023. Epub 2017 Nov 8. Review.

PMID:
29128254
22.

Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.

van der Pol A, Gil A, Silljé HHW, Tromp J, Ovchinnikova ES, Vreeswijk-Baudoin I, Hoes M, Domian IJ, van de Sluis B, van Deursen JM, Voors AA, van Veldhuisen DJ, van Gilst WH, Berezikov E, van der Harst P, de Boer RA, Bischoff R, van der Meer P.

Sci Transl Med. 2017 Nov 8;9(415). pii: eaam8574. doi: 10.1126/scitranslmed.aam8574.

PMID:
29118264
23.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

Saris A, Tomson B, Brand A, Mulder A, Claas FH, Lorinser J, Scharenberg J, van Ham SM, Ten Brinke A, Zwaginga JJ, van der Meer PF.

Blood. 2018 Jan 4;131(1):144-152. doi: 10.1182/blood-2017-07-799270. Epub 2017 Nov 1.

PMID:
29092829
24.

What have we learned about heart failure with mid-range ejection fraction one year after its introduction?

Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CSP, Ponikowski P, Voors AA.

Eur J Heart Fail. 2017 Dec;19(12):1569-1573. doi: 10.1002/ejhf.1058. Epub 2017 Oct 24. Review.

PMID:
29067761
25.

New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals.

Kraja AT, Cook JP, Warren HR, Surendran P, Liu C, Evangelou E, Manning AK, Grarup N, Drenos F, Sim X, Smith AV, Amin N, Blakemore AIF, Bork-Jensen J, Brandslund I, Farmaki AE, Fava C, Ferreira T, Herzig KH, Giri A, Giulianini F, Grove ML, Guo X, Harris SE, Have CT, Havulinna AS, Zhang H, Jørgensen ME, Käräjämäki A, Kooperberg C, Linneberg A, Little L, Liu Y, Bonnycastle LL, Lu Y, Mägi R, Mahajan A, Malerba G, Marioni RE, Mei H, Menni C, Morrison AC, Padmanabhan S, Palmas W, Poveda A, Rauramaa R, Rayner NW, Riaz M, Rice K, Richard MA, Smith JA, Southam L, Stančáková A, Stirrups KE, Tragante V, Tuomi T, Tzoulaki I, Varga TV, Weiss S, Yiorkas AM, Young R, Zhang W, Barnes MR, Cabrera CP, Gao H, Boehnke M, Boerwinkle E, Chambers JC, Connell JM, Christensen CK, de Boer RA, Deary IJ, Dedoussis G, Deloukas P, Dominiczak AF, Dörr M, Joehanes R, Edwards TL, Esko T, Fornage M, Franceschini N, Franks PW, Gambaro G, Groop L, Hallmans G, Hansen T, Hayward C, Heikki O, Ingelsson E, Tuomilehto J, Jarvelin MR, Kardia SLR, Karpe F, Kooner JS, Lakka TA, Langenberg C, Lind L, Loos RJF, Laakso M, McCarthy MI, Melander O, Mohlke KL, Morris AP, Palmer CNA, Pedersen O, Polasek O, Poulter NR, Province MA, Psaty BM, Ridker PM, Rotter JI, Rudan I, Salomaa V, Samani NJ, Sever PJ, Skaaby T, Stafford JM, Starr JM, van der Harst P, van der Meer P; Understanding Society Scientific Group, van Duijn CM, Vergnaud AC, Gudnason V, Wareham NJ, Wilson JG, Willer CJ, Witte DR, Zeggini E, Saleheen D, Butterworth AS, Danesh J, Asselbergs FW, Wain LV, Ehret GB, Chasman DI, Caulfield MJ, Elliott P, Lindgren CM, Levy D, Newton-Cheh C, Munroe PB, Howson JMM; CHARGE EXOME BP, CHD Exome+, Exome BP, GoT2D:T2DGenes Consortia, The UK Biobank Cardio-Metabolic Traits Consortium Blood Pressure Working Group†.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001778. doi: 10.1161/CIRCGENETICS.117.001778.

PMID:
29030403
26.

Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.

Hummel YM, Liu LCY, Lam CSP, Fonseca-Munoz DF, Damman K, Rienstra M, van der Meer P, Rosenkranz S, van Veldhuisen DJ, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Dec;19(12):1651-1660. doi: 10.1002/ejhf.957. Epub 2017 Oct 6.

PMID:
28984057
27.

Vox Sanguinis International Forum on platelet cryopreservation: Summary.

Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M.

Vox Sang. 2017 Oct;112(7):684-688. doi: 10.1111/vox.12533. Epub 2017 Sep 20. No abstract available.

PMID:
28929502
28.

Vox Sanguinis International Forum on platelet cryopreservation.

Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M.

Vox Sang. 2017 Oct;112(7):e69-e85. doi: 10.1111/vox.12532. Epub 2017 Sep 20. No abstract available.

PMID:
28929500
29.

Monitoring storage induced changes in the platelet proteome employing label free quantitative mass spectrometry.

Rijkers M, van den Eshof BL, van der Meer PF, van Alphen FPJ, de Korte D, Leebeek FWG, Meijer AB, Voorberg J, Jansen AJG.

Sci Rep. 2017 Sep 8;7(1):11045. doi: 10.1038/s41598-017-11643-w.

30.

Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO2 Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension.

Klaassen SHC, Liu LCY, Hummel YM, Damman K, van der Meer P, Voors AA, Hoendermis ES, van Veldhuisen DJ.

J Card Fail. 2017 Nov;23(11):777-782. doi: 10.1016/j.cardfail.2017.07.397. Epub 2017 Jul 20.

31.

Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.

Saadah NH, van der Meer PF, Brinkman HJM, de Korte D, Bontekoe IJ, Korsten HH, Middelburg RA, van der Bom JG, Schipperus MR.

Transfusion. 2017 Oct;57(10):2381-2389. doi: 10.1111/trf.14260. Epub 2017 Jul 20.

PMID:
28727139
32.

Platelet storage performance is consistent by donor: a pilot study comparing "good" and "poor" storing platelets.

Bontekoe IJ, van der Meer PF, van den Hurk K, Verhoeven AJ, de Korte D.

Transfusion. 2017 Oct;57(10):2373-2380. doi: 10.1111/trf.14238. Epub 2017 Jul 13.

PMID:
28703861
33.

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Böhm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A; EFFECT-HF Investigators.

Circulation. 2017 Oct 10;136(15):1374-1383. doi: 10.1161/CIRCULATIONAHA.117.027497. Epub 2017 Jul 12.

34.

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.

Liu LCY, Valente MAE, Postmus D, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, van der Meer P, Voors AA.

Cardiovasc Drugs Ther. 2017 Jun;31(3):281-293. doi: 10.1007/s10557-017-6726-1.

35.

Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.

Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P.

JACC Heart Fail. 2017 Jul;5(7):507-517. doi: 10.1016/j.jchf.2017.04.007. Epub 2017 Jun 14.

36.

Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.

Boerman LM, Maass SWMC, van der Meer P, Gietema JA, Maduro JH, Hummel YM, Berger MY, de Bock GH, Berendsen AJ.

Eur J Cancer. 2017 Aug;81:56-65. doi: 10.1016/j.ejca.2017.05.013. Epub 2017 Jun 8.

PMID:
28601706
37.

Comparison of haemostatic function of PAS-C-platelets vs. plasma-platelets in reconstituted whole blood using impedance aggregometry and thromboelastography.

van Hout FMA, Bontekoe IJ, de Laleijne LAE, Kerkhoffs JL, de Korte D, Eikenboom J, van der Bom JG, van der Meer PF.

Vox Sang. 2017 Aug;112(6):549-556. doi: 10.1111/vox.12534. Epub 2017 Jun 9.

PMID:
28597485
38.

Associations between volume status and circulating microRNAs in acute heart failure.

Vegter EL, van der Meer P, Voors AA.

Eur J Heart Fail. 2017 Aug;19(8):1077-1078. doi: 10.1002/ejhf.867. Epub 2017 May 25. No abstract available.

PMID:
28547885
39.

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.

Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, van der Meer P, Damman K, Voors AA, Goldsmith SR.

Clin Res Cardiol. 2017 Oct;106(10):802-812. doi: 10.1007/s00392-017-1122-1. Epub 2017 May 24.

40.

Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure.

Moliner P, Jankowska EA, van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, Polonski L, Meroño O, Voors AA, Ponikowski P, Van der Meer P, Comin-Colet J.

Int J Cardiol. 2017 Sep 15;243:360-366. doi: 10.1016/j.ijcard.2017.04.110. Epub 2017 May 3.

PMID:
28511855
41.

Prevention of red cell storage lesion: a comparison of five different additive solutions.

Lagerberg JW, Korsten H, Van Der Meer PF, De Korte D.

Blood Transfus. 2017 Sep;15(5):456-462. doi: 10.2450/2017.0371-16. Epub 2017 Apr 10.

42.

Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.

Vegter EL, Ovchinnikova ES, Silljé HHW, Meems LMG, van der Pol A, van der Velde AR, Berezikov E, Voors AA, de Boer RA, van der Meer P.

PLoS One. 2017 May 5;12(5):e0177242. doi: 10.1371/journal.pone.0177242. eCollection 2017.

43.

Iron deficiency and red cell indices in patients with heart failure.

Tkaczyszyn M, Comín-Colet J, Voors AA, van Veldhuisen DJ, Enjuanes C, Moliner-Borja P, Rozentryt P, Poloński L, Banasiak W, Ponikowski P, van der Meer P, Jankowska EA.

Eur J Heart Fail. 2018 Jan;20(1):114-122. doi: 10.1002/ejhf.820. Epub 2017 Apr 6.

PMID:
28386910
44.

Comorbidities in Heart Failure.

van der Wal HH, van Deursen VM, van der Meer P, Voors AA.

Handb Exp Pharmacol. 2017;243:35-66. doi: 10.1007/164_2017_27. Review.

PMID:
28382470
45.

Discovery of novel heart rate-associated loci using the Exome Chip.

van den Berg ME, Warren HR, Cabrera CP, Verweij N, Mifsud B, Haessler J, Bihlmeyer NA, Fu YP, Weiss S, Lin HJ, Grarup N, Li-Gao R, Pistis G, Shah N, Brody JA, Müller-Nurasyid M, Lin H, Mei H, Smith AV, Lyytikäinen LP, Hall LM, van Setten J, Trompet S, Prins BP, Isaacs A, Radmanesh F, Marten J, Entwistle A, Kors JA, Silva CT, Alonso A, Bis JC, de Boer R, de Haan HG, de Mutsert R, Dedoussis G, Dominiczak AF, Doney ASF, Ellinor PT, Eppinga RN, Felix SB, Guo X, Hagemeijer Y, Hansen T, Harris TB, Heckbert SR, Huang PL, Hwang SJ, Kähönen M, Kanters JK, Kolcic I, Launer LJ, Li M, Yao J, Linneberg A, Liu S, Macfarlane PW, Mangino M, Morris AD, Mulas A, Murray AD, Nelson CP, Orrú M, Padmanabhan S, Peters A, Porteous DJ, Poulter N, Psaty BM, Qi L, Raitakari OT, Rivadeneira F, Roselli C, Rudan I, Sattar N, Sever P, Sinner MF, Soliman EZ, Spector TD, Stanton AV, Stirrups KE, Taylor KD, Tobin MD, Uitterlinden A, Vaartjes I, Hoes AW, van der Meer P, Völker U, Waldenberger M, Xie Z, Zoledziewska M, Tinker A, Polasek O, Rosand J, Jamshidi Y, van Duijn CM, Zeggini E, Jukema JW, Asselbergs FW, Samani NJ, Lehtimäki T, Gudnason V, Wilson J, Lubitz SA, Kääb S, Sotoodehnia N, Caulfield MJ, Palmer CNA, Sanna S, Mook-Kanamori DO, Deloukas P, Pedersen O, Rotter JI, Dörr M, O'Donnell CJ, Hayward C, Arking DE, Kooperberg C, van der Harst P, Eijgelsheim M, Stricker BH, Munroe PB.

Hum Mol Genet. 2017 Jun 15;26(12):2346-2363. doi: 10.1093/hmg/ddx113.

46.

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.

Tromp J, Khan MA, Klip IT, Meyer S, de Boer RA, Jaarsma T, Hillege H, van Veldhuisen DJ, van der Meer P, Voors AA.

J Am Heart Assoc. 2017 Mar 30;6(4). pii: e003989. doi: 10.1161/JAHA.116.003989.

47.

Serum eye drops: a survey of international production methods.

Marks DC, van der Meer PF; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Vox Sang. 2017 May;112(4):310-317. doi: 10.1111/vox.12502. Epub 2017 Mar 23.

PMID:
28332214
48.

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations.

Vegter EL, Ovchinnikova ES, van Veldhuisen DJ, Jaarsma T, Berezikov E, van der Meer P, Voors AA.

Clin Res Cardiol. 2017 Aug;106(8):598-609. doi: 10.1007/s00392-017-1096-z. Epub 2017 Mar 14.

49.

Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM.

Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van der Meer P, Roos-Hesselink JW, Seferovic P, van Spandonck-Zwarts K, Mbakwem A, Böhm M, Mouquet F, Pieske B, Hall R, Ponikowski P, Bauersachs J.

Eur J Heart Fail. 2017 Sep;19(9):1131-1141. doi: 10.1002/ejhf.780. Epub 2017 Mar 8.

PMID:
28271625
50.

Neuromodulation for systolic heart failure: more than a placebo effect?

Maass AH, DeJongste MJ, van der Meer P.

Eur J Heart Fail. 2017 Mar;19(3):401-403. doi: 10.1002/ejhf.752. No abstract available.

Supplemental Content

Loading ...
Support Center